Biopharmaceutical manufacturer of a drug product for thyroid eye disease.
Issues regarding the improvement of patient access to advanced rare disease therapies. Issues related to pharmaceutical drugs; Issues related to drug pricing; Issues related to drug pricing in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D; Issues related to policies affecting biopharma products coverage and access in Medicare and Medicaid.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
MICHAEL ALEXANDER WILLIAMS CYNTHIA BROWN ELIZABETH GREER DERRICK M WHITE JEFFREY FORBES BARRETT THORNHILL MICHAEL ALEXANDER WILLIAMS CYNTHIA BROWN ELIZABETH GREER DERRICK M WHITE JEFFREY FORBES BARRETT THORNHILL